The page is the record's research on the issuer — no analyst, no rating, no view. # FARON PHARMACEUTICALS OY (AIM: FARN) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing The issuer is FARON PHARMACEUTICALS OY, listed on AIM under ticker FARN, ISIN FI4000153309, LEI 7437009H31TO1DC0EB42. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is Finland (FI). The record holds its listing status as listed, not halted. ## The disclosure read The record holds 77 filings in the twelve months to 2026-11-06, across 60 filing days. The filings are 67 regulatory announcements, 7 director dealings, 2 financial statements and 1 halt and resume. The median gap between filing days is 3 days. The latest filing is a regulatory announcement dated 2026-11-04, 2 days before the record date. On AIM the median filings count is 33.5, the median cadence gap is 7.0 days and the median latency is 4 days across 594 issuers. In the sector the median filings count is 42, the median cadence gap is 6.0 days and the median latency is 4.0 days across 51 issuers. ## Auditor The auditor of record is not on the record. The auditor's location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag reads listed, not halted. ## Orderability For elective professional client the outcome is signal ACM-200, determinable. For eligible counterparty the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 9 research houses: Kempen, Carnegie, Redeye, Inderes, H.C.WAINWRIGHT&CO, Peel Hunt, Kepler Chevreaux, Panmure Gordon and Stifel Research. ## Open research No openly published research notes were found for the issuer. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth No issuer years are sealed. The market's vintage is not sealed and no earliest sealed date is held. The live record began 2026-09-11. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/FARN (identity.isin) - https://api.gleif.org/api/v1/lei-records/7437009H31TO1DC0EB42 (identity.jurisdiction) - https://www.londonstockexchange.com/stock/FARN/faron-pharmaceuticals-oy/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/AIM/FARN (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/ (coverage) - https://mcp.uk-cm-kg.ai/record/AIM/FARN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/AIM/FARN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp